MyFinsight
Home
Blog
About
Net loss
-$782M
(5.21%↑ Y/Y)
Gross product sales
$122M
(-30.68%↓ Y/Y)
Loss before income
taxes
-$767M
(6.23%↑ Y/Y)
Provision for income taxes
$15M
(114.29%↑ Y/Y)
Interest income
$67M
(-17.28%↓ Y/Y)
Product Sales
$94M
(-17.54%↓ Y/Y)
Product And Service
Other
$51M
(82.14%↑ Y/Y)
Total product sales
provision adjustments
$28M
(-54.84%↓ Y/Y)
Returns, rebates and
other fees
-$22M
Loss from operations
-$815M
(10.14%↑ Y/Y)
Total revenue
$145M
(2.11%↑ Y/Y)
Other (expense)
income, net
-$19M
(-337.50%↓ Y/Y)
Wholesaler chargebacks,
discounts and fees
$50M
(-19.35%↓ Y/Y)
Total operating
expenses
$960M
(-8.48%↓ Y/Y)
Research and development
$651M
(-7.00%↓ Y/Y)
Selling, general and
administrative
$216M
(-6.09%↓ Y/Y)
Cost of sales
$93M
(-21.85%↓ Y/Y)
Back
Back
Income Statement
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)
Master Final R&D Day 2021 Slides (09
source: myfinsight.com
Moderna, Inc. (MRNA)